Palantir’s August 3 Earnings: A Growth Machine Running Into a Wall of Skepticism

Palantir faces a 31% YTD stock drop despite 85% revenue growth, with Q2 earnings on Aug 3 testing its AI valuation and competitive moat.

Palantir Technologies heads into its second-quarter earnings report on August 3 carrying a burden that few high-growth software companies expect to shoulder: a stock that has fallen 31.33 percent since the start of the year. At Friday’s close of €107.90, the shares sit 40.05 percent below their 52-week high, having shed 6.74 percent in the past week alone. The contradiction between blistering operational momentum and a sliding share price has become the defining puzzle for investors in the data analytics specialist.

The numbers from the first quarter tell a story of a company firing on all cylinders. Revenue surged 85 percent to $1.63 billion, adjusted earnings per share jumped 153 percent to $0.33, and adjusted free cash flow soared 150 percent to $925 million. Chief executive Alex Karp has laid out a target of $15 billion to $18 billion in free cash flow over the next two years. For the full year 2026, Palantir raised its revenue guidance to a range of $7.65 billion to $7.66 billion, representing 71 percent growth from the prior year. Analysts expect second-quarter revenue of roughly $1.81 billion and earnings per share of $0.34.

Yet the market is demanding more than just growth promises. The valuation remains stretched even after the pullback, leaving the stock vulnerable to profit-taking the moment any softness appears in the growth trajectory. That tension is playing out across the broader software landscape. Hyperscalers including Alphabet have unveiled massive capital expenditure plans, with roughly $725 billion in AI-related investments projected industry-wide for 2026. While those sums validate the AI thesis, they have also created unusual cash-flow strains for some of the largest players — and investors are increasingly penalizing software companies that cannot demonstrate fast, margin-rich returns.

Palantir’s position at the intersection of AI infrastructure and application deployment makes it a bellwether for the next phase of the technology cycle. The company’s proprietary “Ontology” architecture and its ability to operate in secure, classified environments are meant to be its competitive moat. But that differentiation is facing new pressure from Chinese AI model providers such as Moonshot’s Kimi K3 and Z.ai’s GLM-5.2, which are reportedly 60 to 90 percent cheaper than leading US models. For a company that markets itself as “the operating system for the modern enterprise,” the cost advantage of rival models sharpens the need to prove that its closed-environment security capabilities are worth the premium.

The stock’s technical position offers little clarity. It sits in a neutral zone — neither overbought nor oversold — suggesting the market is waiting for a fundamental catalyst rather than a technical one. Analysts remain broadly optimistic, with a consensus price target of €160.97, implying 49.2 percent upside from Friday’s close. But the range of opinions is unusually wide. Citi’s Tyler Radke maintains a buy rating with a $200 target, down from $225, while Jefferies’ Brent Thill rates the stock a sell with a $70 target. That chasm reflects the deep disagreement over whether Palantir’s growth story justifies its valuation multiple.

Institutional investors have been sending mixed signals. Renaissance Technologies trimmed its stake by roughly one-fifth in the first quarter, though it still holds a position worth about $1 billion. Insiders have sold more than $150 million worth of shares over the past three months. Those moves contrast with the company’s aggressive defense of its government business — Palantir recently protested a Defense Intelligence Agency solicitation, a move that temporarily supported the share price and underscored its determination to protect its foothold in the defense sector.

Beyond valuation and competition, a political controversy in the United Kingdom is adding reputational risk. According to a report in The Guardian, lawmakers have warned that Palantir’s access to identifiable patient data from the National Health Service is “dangerous.” The concern centers on a £330 million contract for the Federated Data Platform, under which Palantir reportedly received “unlimited access” to data before pseudonymization, according to an internal NHS memo. Labour MP Rachael Maskell has called for the project to be halted, and colleague Emily Darlington described it as a “significant security risk.” Palantir’s UK country head Louis Mosley defended the company, saying it acts only as a “data processor” with no ability to misuse data. Surveys indicate that roughly 40 percent of the British public distrust the company’s handling of NHS data. The existing contract is up for renewal in 2027.

In Switzerland, Palantir suffered a legal setback when a court dismissed 95 percent of its lawsuit against the magazine Republik, ordering the company to pay court costs. The magazine had reported on a lack of government contracts for Palantir in the country.

The August 3 earnings report will test whether Palantir can resolve the disconnect between its operational strength and its market reception. If the company confirms its elevated growth trajectory and full-year guidance, the bull case — led by Citi — gains credibility. A miss on second-half revenue expectations would bolster the skeptics at Jefferies and others. Options markets are already pricing in significant volatility around the release, a sign that investors are bracing for a decisive move in either direction. The question is whether Palantir’s software can transform from a cost center for tech giants into a profit engine for the broader economy — or whether it will follow the cautious path of IBM and ServiceNow, where strong narratives met a market that wanted hard proof.